SUFFERERS of Crohn’s disease (CrD) worldwide could potentially be one step away from reaping the benefits of a cure for their condition, changing lives on a global scale.
Prof John Hermon-Taylor, Visiting Professor, King’s College London, London, UK, who has spent the last 30 years dedicating his life to finding a cure for the debilitating condition, claims that his work could revolutionise the lives of 115,000 people in the UK.
Together, Prof Hermon-Taylor and his research team have developed a test for the bacterium, Mycobacterium avium subspecies paratuberculosis (MAP), which cannot be seen through a microscope in human tissues and is thus extremely difficult to study, and a vaccine that they claim as a cure.
“It is going to be a game changer. MAP has been a candidate for causing Crohn’s for over 100 years and no-one has been able to see it. I have invented a new test to see the bug. It has the potential to put Crohn’s into lasting remission,” Prof Hermon-Taylor commented.
People of all ages are affected by Crohn’s, most commonly presented as inflammatory bowel disease and ulcerative colitis. Many experience symptoms such as constant diarrhoea, chronic fatigue, and abdominal pain; patients often require surgery to remove sections of their intestine or bowel.
Yet now this recent research progress, which has cost £70,000, has the ability to inspire new hope in the hearts of CrD patients; the vaccine is ready to be tested on humans after successful trials on cattle and could be available on the NHS within a year.
“This will be worldwide, not just for Britain,” concluded Prof Hermon-Taylor, “It will be a victory for what I call the little people – I am one of them. We shall win.”